Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells

BMC Medical Genomics

Volumn 2, Issue , 2009, Pages

  Bowen, Nathan J ^a,b   Walker, L Deette ^a,b   Matyunina, Lilya V ^a,b   Logani, Sanjay ^c   Totten, Kimberly A ^a,b   Benigno, Benedict B ^b   McDonald, John F ^a,b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b Ovarian Cancer Institute   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFFIN;

ADULT; ARTICLE; CANCER CELL; CELL CYCLE REGULATION; CELL SURFACE; CONTROLLED STUDY; EMBEDDING; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; MOLECULAR INTERACTION; MULTIPOTENT STEM CELL; NUCLEOTIDE SEQUENCE; OVARY; OVARY ADENOCARCINOMA; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UTERINE TUBE; ADENOCARCINOMA; ADULT STEM CELL; CANCER STEM CELL; CELL CYCLE; CELL TRANSFORMATION; CYTOLOGY; FROZEN SECTION; GENE EXPRESSION REGULATION; GENETICS; LASER; METABOLISM; MICRODISSECTION; OVARY TUMOR; PATHOLOGY;

ADENOCARCINOMA, PAPILLARY; ADULT STEM CELLS; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; FEMALE; FROZEN SECTIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LASERS; MICRODISSECTION; MULTIPOTENT STEM CELLS; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; OVARY; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 74849123453     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-2-71     Document Type: Article

References (84)

1. A Snapshot of Ovarian Cancer. http://planning.cancer.gov/disease/Ovarian- Snapshot.pdf
2. Cancer Facts and Figures 2009. http://www.cancer.org/downloads/STT/ 500809web.pdf
3. Ovarian Surface Epithelial-Stromal Tumors. RE Scully PB Clement RH Young, STERNBERG'S Diagnostic Surgical Pathology Philadelphia, PA: Lippincott Williams & Wilkins, Mills SE, 2004 2543 2578
4. Ovarian surface epithelium: biology, endocrinology, and pathology. N Auersperg AS Wong KC Choi SK Kang PC Leung, Endocr Rev 2001 22 255 288 10.1210/er.22.2.255 11294827
5. Cellular origin of cancer: dedifferentiation or stem cell maturation arrest? S Sell, Environ Health Perspect 1993 5 15 26 10.2307/3431838
6. BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis. JM Piek RH Verheijen P Kenemans LF Massuger H Bulten PJ van Diest, Gynecol Oncol 2003 90 491 10.1016/S0090-8258(03)00365-2 12893227
7. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? L Dubeau, Gynecol Oncol 1999 72 437 442 10.1006/gyno.1998.5275 10053122
8. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. F Medeiros MG Muto Y Lee JA Elvin MJ Callahan C Feltmate JE Garber DW Cramer CP Crum, Am J Surg Pathol 2006 30 230 236 10.1097/01.pas.0000180854.28831.77 16434898
9. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. Y Lee A Miron R Drapkin MR Nucci F Medeiros A Saleemuddin J Garber C Birch H Mou RW Gordon, et al. J Pathol 2007 211 26 35 10.1002/path.2091 17117391
10. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. A Finch P Shaw B Rosen J Murphy SA Narod TJ Colgan, Gynecol Oncol 2006 100 58 64 10.1016/j.ygyno.2005.06.065 16137750
11. Early de novo ovarian carcinoma. A study of fourteen cases. DA Bell RE Scully, Cancer 1994 73 1859 1864 10.1002/1097-0142(19940401)73:7<1859:AID- CNCR2820730714>3.0.CO;2-L 8137211
12. Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics. PP Szotek HL Chang K Brennand A Fujino R Pieretti-Vanmarcke C Lo Celso D Dombkowski F Preffer KS Cohen J Teixeira PK Donahoe, Proc Natl Acad Sci USA 2008 105 12469 12473 10.1073/pnas.0805012105 18711140
13. Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract. W Cheng J Liu H Yoshida D Rosen H Naora, Nat Med 2005 11 531 537 10.1038/nm1230 15821746
14. Stem cells, cancer, and cancer stem cells. T Reya SJ Morrison MF Clarke IL Weissman, Nature 2001 414 105 111 10.1038/35102167 11689955
15. History of Cancer Stem Cells. S Sell, Regulatory Networks in Stem Cells. [Turksen K (Series Editor); Stem Cell Biology and Regenerative Medicine] New York, NY: Humana Press, Rajasekhar V, Mohan C, 2009
16. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. SJ Morrison AC Spradling, Cell 2008 132 598 611 10.1016/j.cell.2008.01.038 18295578
17. Asymmetric and symmetric stem-cell divisions in development and cancer. SJ Morrison J Kimble, Nature 2006 441 1068 1074 10.1038/nature04956 16810241
18. Stems cells and the pathways to aging and cancer. DJ Rossi CH Jamieson IL Weissman, Cell 2008 132 681 696 10.1016/j.cell.2008.01.036 18295583
19. Incessant ovulation-a factor in ovarian neoplasia? MF Fathalla, Lancet 1971 2 163 10.1016/S0140-6736(71)92335-X 4104488
20. Oxidative damage to DNA of ovarian surface epithelial cells affected by ovulation: carcinogenic implication and chemoprevention. WJ Murdoch JF Martinchick, Exp Biol Med (Maywood) 2004 229 546 552 15169974
21. Babelomics: advanced functional profiling of transcriptomics, proteomics and genomics experiments. F Al-Shahrour J Carbonell P Minguez S Goetz A Conesa J Tarraga I Medina E Alloza D Montaner J Dopazo, Nucleic Acids Res 2008 36 341 346 10.1093/nar/gkn318 18515841
22. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. RT Marquez KA Baggerly AP Patterson J Liu R Broaddus M Frumovitz EN Atkinson DI Smith L Hartmann D Fishman, et al. Clin Cancer Res 2005 11 6116 6126 10.1158/1078-0432.CCR-04-2509 16144910
23. Genomica. Segal Lab, http://genomica.weizmann.ac.il/
24. Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate. S Draghici P Khatri P Bhavsar A Shah SA Krawetz MA Tainsky, Nucleic Acids Res 2003 31 3775 3781 10.1093/nar/gkg624 12824416
25. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. KA Brown JA Pietenpol HL Moses, J Cell Biochem 2007 101 9 33 10.1002/jcb.21255 17340614
26. Smad6 inhibits signalling by the TGF-beta superfamily. T Imamura M Takase A Nishihara E Oeda J Hanai M Kawabata K Miyazono, Nature 1997 389 622 626 10.1038/39355 9335505
27. Transforming growth factor-beta1 represses E-cadherin production via slug expression in lens epithelial cells. J Choi SY Park CK Joo, Invest Ophthalmol Vis Sci 2007 48 2708 2718 10.1167/iovs.06-0639 17525203
28. The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. A Dhasarathy M Kajita PA Wade, Mol Endocrinol 2007 21 2907 2918 10.1210/me.2007-0293 17761946
29. Transforming growth factor-beta1-mediated Slug and Snail transcription factor up-regulation reduces the density of Langerhans cells in epithelial metaplasia by affecting E-cadherin expression. M Herfs P Hubert N Kholod JH Caberg C Gilles G Berx P Savagner J Boniver P Delvenne, Am J Pathol 2008 172 1391 1402 10.2353/ajpath.2008.071004 18385519
30. Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. M Stander U Naumann W Wick M Weller, Cell Tissue Res 1999 296 221 227 10.1007/s004410051283 10382266
31. Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. C Kosinski VS Li AS Chan J Zhang C Ho WY Tsui TL Chan RC Mifflin DW Powell ST Yuen, et al. Proc Natl Acad Sci USA 2007 104 15418 15423 10.1073/pnas.0707210104 17881565
32. Wnt signaling and stem cell control. R Nusse, Cell Res 2008 18 523 527 10.1038/cr.2008.47 18392048
33. The Hedgehog and Wnt signalling pathways in cancer. J Taipale PA Beachy, Nature 2001 411 349 354 10.1038/35077219 11357142
34. Tissue repair and stem cell renewal in carcinogenesis. PA Beachy SS Karhadkar DM Berman, Nature 2004 432 324 331 10.1038/nature03100 15549094
35. Wnt5a inhibits canonical Wnt signaling in hematopoietic stem cells and enhances repopulation. MJ Nemeth L Topol SM Anderson Y Yang DM Bodine, Proc Natl Acad Sci USA 2007 104 15436 15441 10.1073/pnas.0704747104 17881570
36. Wnt2b inhibits differentiation of retinal progenitor cells in the absence of Notch activity by downregulating the expression of proneural genes. F Kubo M Takeichi S Nakagawa, Development 2005 132 2759 2770 10.1242/dev.01856 15901663
37. Wnt7a is a suppressor of cell death in the female reproductive tract and is required for postnatal and estrogen-mediated growth. L Carta D Sassoon, Biol Reprod 2004 71 444 454 10.1095/biolreprod.103.026534 15070830
38. The WNT receptor FZD7 contributes to self-renewal signaling of human embryonic stem cells. K Melchior J Weiss H Zaehres YM Kim C Lutzko N Roosta J Hescheler M Muschen, Biol Chem 2008 389 897 903 10.1515/BC.2008.108 18681827
39. The inhibitory effects of Disabled-2 (Dab2) on Wnt signaling are mediated through Axin. Y Jiang C Prunier PH Howe, Oncogene 2008 27 1865 1875 10.1038/sj.onc.1210829 17922036
40. The zic1 gene is an activator of Wnt signaling. CS Merzdorf HL Sive, Int J Dev Biol 2006 50 611 617 10.1387/ijdb.052110cm 16892174
41. Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. YF Wong TH Cheung KW Lo SF Yim NS Siu SC Chan TW Ho KW Wong MY Yu VW Wang, et al. Oncogene 2007 26 1971 1982 10.1038/sj.onc.1209986 17043662
42. Transcription factors Zic1 and Zic2 bind and transactivate the apolipoprotein E gene promoter. E Salero R Perez-Sen J Aruga C Gimenez F Zafra, J Biol Chem 2001 276 1881 1888 10.1074/jbc.M007008200 11038359
43. Apolipoprotein E is required for cell proliferation and survival in ovarian cancer. YC Chen G Pohl TL Wang PJ Morin B Risberg GB Kristensen A Yu B Davidson M Shih Ie, Cancer Res 2005 65 331 337 15665311
44. Wnt/Notch signalling and information processing during development. P Hayward T Kalmar AM Arias, Development 2008 135 411 424 10.1242/dev.000505 18192283
45. Notch signaling: control of cell communication and cell fate. EC Lai, Development 2004 131 965 973 10.1242/dev.01074 14973298
46. Jagged-1 and Notch3 Juxtacrine Loop Regulates Ovarian Tumor Growth and Adhesion. J Choi JT Park B Davidson PJ Morin IM Shih TL Wang, Cancer Res 2008 68 5717 5723
47. Notch3 gene amplification in ovarian cancer. JT Park M Li K Nakayama TL Mao B Davidson Z Zhang RJ Kurman CG Eberhart IM Shih TL Wang, Cancer Res 2006 66 6312 6318 10.1158/0008-5472.CAN-05-3610 16778208
48. NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. N Yamaguchi T Oyama E Ito H Satoh S Azuma M Hayashi K Shimizu R Honma Y Yanagisawa A Nishikawa, et al. Cancer Res 2008 68 1881 1888 10.1158/0008-5472.CAN-07-1597 18339869
49. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer. H Taniguchi H Yamamoto N Akutsu K Nosho Y Adachi K Imai Y Shinomura, J Pathol 2007 213 131 139 10.1002/path.2216 17724792
50. Evidence that the WNT-inducible growth arrest-specific gene 1 encodes an antagonist of sonic hedgehog signaling in the somite. CS Lee L Buttitta CM Fan, Proc Natl Acad Sci USA 2001 98 11347 11352 10.1073/pnas.201418298 11572986
51. Novel genes regulated by Sonic Hedgehog in pluripotent mesenchymal cells. WJ Ingram CA Wicking SM Grimmond AR Forrest BJ Wainwright, Oncogene 2002 21 8196 8205 10.1038/sj.onc.1205975 12444557
52. Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways. V Easwaran M Pishvaian, Salimuddin S Byers, Curr Biol 1999 9 1415 1418 10.1016/S0960-9822(00)80088-3 10607566
53. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. RW Storms AP Trujillo JB Springer L Shah OM Colvin SM Ludeman C Smith, Proc Natl Acad Sci USA 1999 96 9118 9123 10.1073/pnas.96.16.9118 10430905
54. Cellular retinoic acid-binding protein II is a direct transcriptional target of MycN in neuroblastoma. A Gupta BR Williams SM Hanash J Rawwas, Cancer Res 2006 66 8100 8108 10.1158/0008-5472.CAN-05-4519 16912187
55. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. TT Schug DC Berry IA Toshkov L Cheng AY Nikitin N Noy, Proc Natl Acad Sci USA 2008 105 7546 7551 10.1073/pnas. 0709981105 18495924
56. Identification of the retinoic acid-inducible all-trans-retinoic acid 4-hydroxylase. JA White YD Guo K Baetz B Beckett-Jones J Bonasoro KE Hsu FJ Dilworth G Jones M Petkovich, J Biol Chem 1996 271 29922 29927 10.1074/jbc.271.47.29922 8939936
57. The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures. S Abu-Abed P Dolle D Metzger B Beckett P Chambon M Petkovich, Genes Dev 2001 15 226 240 10.1101/gad.855001 11157778
58. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. A Subramanian P Tamayo VK Mootha S Mukherjee BL Ebert MA Gillette A Paulovich SL Pomeroy TR Golub ES Lander JP Mesirov, Proc Natl Acad Sci USA 2005 102 15545 15550 10.1073/pnas.0506580102 16199517
59. Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. AC Boquest A Shahdadfar K Fronsdal O Sigurjonsson SH Tunheim P Collas JE Brinchmann, Mol Biol Cell 2005 16 1131 1141 10.1091/mbc.E04-10-0949 15635089
60. Cancer stem cells: models and concepts. P Dalerba RW Cho MF Clarke, Annu Rev Med 2007 58 267 284 10.1146/annurev.med.58.062105.204854 17002552 (Pubitemid 46706514)
61. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. AB Alvero R Chen HH Fu M Montagna PE Schwartz T Rutherford DA Silasi KD Steffensen M Waldstrom I Visintin G Mor, Cell Cycle 2009 8 158 166 19158483
62. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. S Zhang C Balch MW Chan HC Lai D Matei JM Schilder PS Yan TH Huang KP Nephew, Cancer Res 2008 68 4311 4320 10.1158/0008-5472.CAN-08- 0364 18519691
63. Lhx2 expression promotes self-renewal of a distinct multipotential hematopoietic progenitor cell in embryonic stem cell-derived embryoid bodies. L Dahl K Richter AC Hagglund L Carlsson, PLoS ONE 2008 3 2025 10.1371/journal. pone.0002025 18431502
64. Lhx2 maintains stem cell character in hair follicles. H Rhee L Polak E Fuchs, Science 2006 312 1946 1949 10.1126/science.1128004 16809539
65. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. HY Chang JB Sneddon AA Alizadeh R Sood RB West K Montgomery JT Chi M van de Rijn D Botstein PO Brown, PLoS Biol 2004 2 7 10.1371/journal.pbio.0020007 14737219
66. Predictive value of Aurora-A/STK15 expression for late stage epithelial ovarian cancer patients treated by adjuvant chemotherapy. S Lassmann Y Shen U Jutting P Wiehle A Walch G Gitsch A Hasenburg M Werner, Clin Cancer Res 2007 13 4083 4091 10.1158/1078-0432.CCR-06-2775 17634533
67. Molecular cloning of pituitary tumor transforming gene 1 from ovarian tumors and its expression in tumors. R Puri A Tousson L Chen SS Kakar, Cancer Lett 2001 163 131 139 10.1016/S0304-3835(00)00688-1 11163117
68. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. KW Orford DT Scadden, Nat Rev Genet 2008 9 115 128 10.1038/nrg2269 18202695
69. The cell of origin of ovarian epithelial tumours. L Dubeau, Lancet Oncol 2008 9 1191 1197 10.1016/S1470-2045(08)70308-5 19038766
70. Mechanisms of asymmetric stem cell division. JA Knoblich, Cell 2008 132 583 597 10.1016/j.cell.2008.02.007 18295577
71. Loss of a quiescent niche but not follicle stem cells in the absence of bone morphogenetic protein signaling. K Kobielak N Stokes J de la Cruz L Polak E Fuchs, Proc Natl Acad Sci USA 2007 104 10063 10068 10.1073/pnas.0703004104 17553962
72. Induction of proliferation in the primate ovarian surface epithelium in vivo. JW Wright T Pejovic J Fanton RL Stouffer, Hum Reprod 2008 23 129 138 10.1093/humrep/dem347 18000169
73. Attempts to stimulate proliferation of the germinal epithelium of the ovary. K Stein E Allen, Anat Rec 1942 82 1 9 10.1002/ar.1090820102
74. Proliferating cell nuclear antigen immunoreactivity in the ovarian surface epithelium of mice of varying ages and total lifetime ovulation number following ovulation. OL Tan JS Fleming, Biol Reprod 2004 71 1501 1507 10.1095/biolreprod.104.030460 15229142
75. Morphologic responses of the mouse ovarian surface epithelium to ovulation and steroid hormonal milieu. GS Gotfredson WJ Murdoch, Exp Biol Med (Maywood) 2007 232 277 280 17259335
76. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. JP Chute GG Muramoto J Whitesides M Colvin R Safi NJ Chao DP McDonnell, Proc Natl Acad Sci USA 2006 103 11707 11712 10.1073/pnas.0603806103 16857736
77. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. XC He J Zhang WG Tong O Tawfik J Ross DH Scoville Q Tian X Zeng X He LM Wiedemann, et al. Nat Genet 2004 36 1117 1121 10.1038/ng1430 15378062
78. Transcriptional regulation of stellate cell activation. SL Friedman, J Gastroenterol Hepatol 2006 3 79 83 10.1111/j.1440-1746.2006.04585.x (Pubitemid 44266557)
79. Cyclin E deregulation alters the biologic properties of ovarian cancer cells. I Bedrosian KH Lu C Verschraegen K Keyomarsi, Oncogene 2004 23 2648 2657 10.1038/sj.onc.1207408 15007381
80. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. F Courjal G Louason P Speiser D Katsaros R Zeillinger C Theillet, Int J Cancer 1996 69 247 253 10.1002/(SICI)1097-0215(19960822)69: 4<247:AID-IJC1>3.0.CO;2-X 8797862
81. Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study. J Farley LM Smith KM Darcy E Sobel D O'Connor B Henderson LE Morrison MJ Birrer, Cancer Res 2003 63 1235 1241 12649182
82. Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma. DG Rosen G Yang MT Deavers A Malpica JJ Kavanagh GB Mills J Liu, Cancer 2006 106 1925 1932 10.1002/cncr.21767 16568440
83. Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup. JM Schildkraut PG Moorman AE Bland S Halabi B Calingaert R Whitaker PS Lee T Elkins-Williams RC Bentley JR Marks A Berchuck, Cancer Epidemiol Biomarkers Prev 2008 17 585 593 10.1158/1055-9965.EPI-07-0596 18349276
84. An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. TC Hallstrom S Mori JR Nevins, Cancer Cell 2008 13 11 22 10.1016/j.ccr.2007.11.031 18167336